Previous research has found that GPRC6A(-/-) male mice exhibit osteoporosis and metabolic syndrome, such as increased weight and higher fat content, hyperglycemia, hyperphosphatemia, hypercalciuria, and feminization (17). Here, GPRC6A is linked to osteoporosis.